Anzeige
Mehr »
Login
Montag, 30.09.2024 Börsentäglich über 12.000 News von 692 internationalen Medien
Aktuelle News: Größter Player im Valley der 1.000%-er!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
621 Leser
Artikel bewerten:
(2)

360Quadrants: MarketsandMarkets Releases 360 Quadrant of Top 20 Cybersecurity Software for 2022

CHICAGO, Jan. 18, 2022 /PRNewswire/ -- MarketsandMarkets has released 360 Quadrant for Best Cybersecurity Software vendors to help businesses make quicker and more informed decisions. Ranking quadrants are generated post-analysis of companies based on product portfolios and business strategies and will be updated every six months based on market and regional analysis and developments in the Cybersecurity industry. Of 120 parameters, the top criteria for company evaluation were Risk and Compliance Management, Security and Vulnerability Management, Identity and Access Management (IAM), Unified Threat Management (UTM), and SIEM.

Cybersecurity Software is the program used for the protection of network, device, or any system from cyberattacks. Cyberattacks are aimed to access, change, or destroy sensitive data at an enterprise level or personal level. Cybersecurity software offers multiple levels of security across devices and networks. Important features of cybersecurity software include security and vulnerability management, cloud security, network security, and disaster recovery. Growing cyberattacks is one of the major factors driving the cybersecurity market. The increasing demand for cybersecurity mesh and cyber-savvy boards is also fuelling the growth of the market.

CATEGORIZATION OF CYBERSECURITY SOFTWARE VENDORS ON 360QUADRANTS

Cybersecurity Software vendors' evaluation was conducted over 82 companies, of which the top 20 were categorized and placed on a quadrant under Visionary Leaders, Innovators, Dynamic Differentiators, and Emerging Leaders.

Microsoft, AWS, Palo Alto, IBM, McAfee, Trend Micro, Mandiant (FireEye), Fortinet, and Cisco have been identified as visionary leaders as they have established product portfolios and a robust market presence and business strategy.

Alert Logic, Malwarebytes, Avast, OpenText (Webroot), and eSentire have been identified as innovators as they have focused product portfolios and an innovative business strategy, which helps them in setting new trends in the market.

Arctic Wolf, Code42, and Havoc Shield have been identified as emerging companies as they have a niche product offering and a decent business strategy, which helps them in having consistent growth.

Qualys, RSA Security, and F5 Networks have been recognized as dynamic differentiators as they have an innovative portfolio of solutions and services.

360Quadrants Scoring Methodology

360Quadrants assessed some of the Top Cybersecurity Software providers. These vendors were assessed based on more than 120 specifically selected parameters, which were finalized based on the product and business strategies of the software provider, and the data received from the buyers as well as the industry experts. All these parameters were assigned a specific weightage, post which they were measured as well. This study also helps the analysts calculate the total score based on which cybersecurity software vendors were ranked and positioned on 360Quadrants.

About MarketsandMarkets

MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats, which will impact 70% to 80% of worldwide companies' revenues. Currently, servicing 7500 customers worldwide, including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions.

Our 850 full-time analysts and SMEs at MarketsandMarkets are tracking global high-growth markets following the Growth Engagement Model - GEM. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify the most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high-growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for a deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Agney Sugla
agney@marketsandmarkets.com
630 Dundee Road, Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441

© 2022 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.